Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program
Authors
Keywords
-
Journal
Molecular Autism
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-11
DOI
10.1186/s13229-022-00505-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects
- (2021) Sigurlaug H. Hafliðadóttir et al. Trials
- Sequential multiple assignment randomized trial studies should report all key components: a systematic review
- (2021) Theophile Bigirumurame et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Lancet Commission on the future of care and clinical research in autism
- (2021) Catherine Lord et al. LANCET
- Social cognition in adults with autism spectrum disorders: Validation of the Edinburgh Social Cognition Test (ESCoT)
- (2020) R. Asaad Baksh et al. CLINICAL NEUROPSYCHOLOGIST
- The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification
- (2020) James C. McPartland et al. Frontiers in Integrative Neuroscience
- Online Patient Recruitment in Clinical Trials: A Systematic Review and Meta Analysis (Preprint)
- (2020) Mette Brøgger-Mikkelsen et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
- (2020) Spyridon Siafis et al. Molecular Autism
- Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
- (2020) Skylar Luu et al. Brain Sciences
- An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder
- (2019) Seth L. Ness et al. Frontiers in Neuroscience
- Effect of Wearable Digital Intervention for Improving Socialization in Children With Autism Spectrum Disorder
- (2019) Catalin Voss et al. JAMA Pediatrics
- Patients with autism spectrum disorders display reproducible functional connectivity alterations
- (2019) Štefan Holiga et al. Science Translational Medicine
- A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
- (2019) Karen J. Parker et al. Science Translational Medicine
- A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
- (2019) Federico Bolognani et al. Science Translational Medicine
- Early Life Adversity and Adult Social Behavior: Focus on Arginine Vasopressin and Oxytocin as Potential Mediators
- (2019) Nine F. Kompier et al. Frontiers in Behavioral Neuroscience
- Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
- (2019) Marko Curkovic et al. Frontiers in Psychiatry
- Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
- (2019) Hans‐Georg Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predictors of quality of life for autistic adults
- (2018) David Mason et al. Autism Research
- Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus
- (2018) Andrea W.M. Evers et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis
- (2018) David Fraguas et al. SCHIZOPHRENIA BULLETIN
- A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder
- (2018) Ilaria Cataldo et al. Frontiers in Molecular Neuroscience
- Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs
- (2018) K. Kubo et al. ACTA PSYCHIATRICA SCANDINAVICA
- In Search of Biomarkers for Autism Spectrum Disorder
- (2018) Marta Del Valle Rubido et al. Autism Research
- Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis
- (2018) Ramona Meister et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
- (2017) Anne Masi et al. Neuroscience Bulletin
- The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation
- (2017) Tony Charman et al. Molecular Autism
- Sequential multiple assignment randomization trials with enrichment design
- (2016) Ying Liu et al. BIOMETRICS
- Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation
- (2016) Eric T. Dobson et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
- (2016) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems
- (2015) Traolach S. Brugha et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach
- (2015) Hasane Ratni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis
- (2015) A Masi et al. Translational Psychiatry
- Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications
- (2015) Heejeong Yoo Experimental Neurobiology
- Placebo Response in Antipsychotic Clinical Trials
- (2014) Bret R. Rutherford et al. JAMA Psychiatry
- A Model of Placebo Response in Antidepressant Clinical Trials
- (2013) Bret R. Rutherford et al. AMERICAN JOURNAL OF PSYCHIATRY
- Baseline Factors Predicting Placebo Response to Treatment in Children and Adolescents With Autism Spectrum Disorders
- (2013) Bryan H. King et al. JAMA Pediatrics
- A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites
- (2012) Boadie W Dunlop et al. NEUROPSYCHOPHARMACOLOGY
- Behavioral interventions in children and adolescents with autism spectrum disorder
- (2011) Geraldine Dawson et al. CURRENT OPINION IN PEDIATRICS
- Site Versus Centralized Raters in a Clinical Depression Trial
- (2010) Kenneth A. Kobak et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
- (2009) Shahin Akhondzadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now